Edition:
India

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

937.10INR
3:49pm IST
Change (% chg)

Rs3.20 (+0.34%)
Prev Close
Rs933.90
Open
Rs937.80
Day's High
Rs950.00
Day's Low
Rs930.35
Volume
450,220
Avg. Vol
1,095,396
52-wk High
Rs1,745.00
52-wk Low
Rs705.75

WCKH.NS

Chart for WCKH.NS

About

Wockhardt Limited (Wockhardt) is an India-based pharmaceutical and biotechnology company. The Company is focused in biotech research program for the development of diabetes related treatment. It has approximately three research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of... (more)

Overall

Beta: 1.18
Market Cap(Mil.): Rs103,204.30
Shares Outstanding(Mil.): 110.51
Dividend: 20.00
Yield (%): 2.68

Financials

  WCKH.NS Industry Sector
P/E (TTM): 31.91 35.27 36.17
EPS (TTM): 29.27 -- --
ROI: 6.22 14.76 14.01
ROE: 8.58 15.84 15.22

FDA finds Indian drug maker Wockhardt hid failed tests

MUMBAI Indian drugmaker Wockhardt hid the results of failed tests and deleted data from its systems at a plant in western India, according to a report by the U.S. Food and Drug Administration sent to the company earlier this month and seen by Reuters.

28 Jan 2016

U.S. regulator finds Indian drug maker Wockhardt hid failed tests

MUMBAI Indian drugmaker Wockhardt hid the results of failed tests and deleted data from its systems at a plant in western India, according to a report by the U.S. Food and Drug Administration sent to the company earlier this month and seen by Reuters.

28 Jan 2016

US regulator finds Indian drug maker Wockhardt hid failed tests

MUMBAI, Jan 28 Indian drugmaker Wockhardt hid the results of failed tests and deleted data from its systems at a plant in western India, according to a report by the U.S. Food and Drug Administration sent to the company earlier this month and seen by Reuters.

28 Jan 2016

BUZZ-India's Wockhardt pares losses after co clarifies on FDA concerns

** Shares in Wockhardt recover to trade 2.72 pct lower after falling as much as 11 pct earlier

18 Jan 2016

Earnings vs. Estimates